Results 261 to 270 of about 1,444,670 (278)

Cardiac myosin inhibitors in hypertrophic cardiomyopathy: the need for precision medicine

European Heart Journal
openaire   +2 more sources

Efficacy and safety of cardiac myosin inhibitors for symptomatic hypertrophic cardiomyopathy: a meta-analysis of randomized controlled trials

Frontiers in Cardiovascular Medicine
Madiha Shāh, Ateesh Kumar, Aashish Meghjiani   +2 more
exaly  

Development of clinically viable non-muscle myosin II small molecule inhibitors

Cell
Courtney A Miller, Madalyn Hafenbreidel, Erica J Young   +2 more
exaly  

Emerging treatments in hypertrophic cardiomyopathy: a focus on cardiac myosin inhibitors

Expert Opinion on Pharmacotherapy
Stuti Shah, Mohammed Abusafia, Susan Keen, Milind Y. Desai   +3 more
openaire   +1 more source

AKT question relating to cardiac myosin inhibitor interactions

InnovAiT: Education and inspiration for general practice
openaire   +1 more source

AKT answer relating to cardiac myosin inhibitor interactions

InnovAiT: Education and inspiration for general practice
openaire   +1 more source

Cardiac Myosin Inhibitors: Expanding the Horizon for Hypertrophic Cardiomyopathy Management

Annals of Pharmacotherapy
Connie H Yoon, Alyssa Meester, Adam Smith   +2 more
exaly  

The Efficacy of Cardiac Myosin Inhibitors Versus Placebo in Patients With Symptomatic Hypertrophic Cardiomyopathy: A Meta-Analysis and Systematic Review

American Journal of Cardiology
George V Moukarbel, Rachel Royfman, Khalid Hamid Changal   +2 more
exaly  

[Mechanism of action and clinical applications of cardiac myosin inhibitors].

Zhonghua xin xue guan bing za zhi
X Y, Ren, Z, Tian, S Y, Zhang
openaire   +1 more source

Short-term incidence and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy receiving cardiac myosin inhibitors: A systematic review and meta-analysis

International Journal of Cardiology
Andrew W Teh
exaly